ClinicalTrials.Veeva

Menu

TcMS to Treat Ventricular Tachycardia

University of Pennsylvania logo

University of Pennsylvania

Status

Withdrawn

Conditions

Ventricular Tachycardia

Treatments

Device: TcMS

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Open label study of transcutaneous magnetic stimulation targeting the stellate ganglion in patients with ventricular tachycardia

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >18years
  • Documented ventricular tachycardia within the preceding 72 hours

Exclusion criteria

  • Pregnancy
  • Implanted ventricular assist device
  • Metal implanted in heard or neck (except the mouth)
  • Implanted medication pumps
  • Cochlear implant
  • Implanted brain stimulator
  • Ocular implant
  • History of malignancy in the region of stimulation (neck)

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

Transcutaneous magnetic stimulation
Experimental group
Description:
Transcutaneous magnetic stimulation targeting the stellate ganglion
Treatment:
Device: TcMS

Trial contacts and locations

1

Loading...

Central trial contact

Timothy Markman, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems